Rapid Micro Biosystems chooses new Chief Commercial Officer

Andy Keys has been chosen to oversee the automation solutions provider's global sales, service, and validation teams

Rapid Micro Biosystems, a life sciences technology company providing automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to announce the appointment of veteran life sciences executive Andy Keys to the newly created position of Chief Commercial Officer (CCO).

Keys joins Rapid Micro from Quanterix Corporation (Quanterix), where he most recently served as Senior Vice President, Global Commercial Operations. Drawing upon two decades of experience as a biopharmaceutical scientist, commercial leader, and life sciences executive, he will oversee Rapid Micro's global sales, service, and validation teams beginning October 2021.

"We are very pleased to welcome Andy to the Rapid Micro team," said President and CEO Robert Spignesi. "His leadership record delivering global growth for life sciences technology companies offers an ideal fit for this new position, helping us to ensure that we are positioned for success in the years to come."

Prior to Quanterix, Keys excelled in sales leadership roles at SomaLogic and Molecular Devices after starting his career as a field application scientist. He holds a master's degree in Biomedical Science from University of Massachusetts Medical School and a bachelor's degree in Chemistry from Southern Illinois University.

"I'm excited to join Rapid Micro and lead a team that is setting the world standard for microbiology quality control automation," said Keys. "The Growth Direct System has vast commercial potential with its robust technology, proven validation process, and highly experienced support team. I am eager to help the company realise that potential."

You may also like